Transgene S.A.

Transgene S.A.verified

TRGNF

Price:

$1

Market Cap:

$122.00M

Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a therapeutic vaccine, which is in phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in phase I/IIa clinical trial for the treatment of various solid tumors, such as gastrointestinal adenocarcinoma comprising stomach, pancreas, and colon; and BT-001, an oncolytic virus, whic...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

TRGNF

The ROE as of December 2025 (TTM) for Transgene S.A. (TRGNF) is -634.16%

According to Transgene S.A.’s latest financial reports and current stock price. The company's current ROE is -634.16%. This represents a change of -183.02% compared to the average of 763.84% of the last 4 quarters.

Transgene S.A. (TRGNF) Historical ROE (quarterly & annually)

How has TRGNF ROE performed in the past?

The mean historical ROE of Transgene S.A. over the last ten years is -87.02%. The current -634.16% ROE has changed 628.76% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's ROE was at its highest in in the June 2024 quarter at 2.68%. The ROE was at its lowest in in the December 2024 quarter at -115.01%.

Quarterly (TTM)
Annual

Average

-87.02%

Median

-70.46%

Minimum

-223.43%

Maximum

21.87%

Transgene S.A. (TRGNF) ROE by Quarter and Year

Discovering the peaks and valleys of Transgene S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 191.31%

Maximum Annual ROE = 21.87%

Minimum Annual Increase = -230.88%

Minimum Annual ROE = -223.43%

Quarterly (TTM)
Annual
YearROEChange
2024-223.43%56.23%
2023-143.02%64.95%
2022-86.70%191.31%
2021-29.76%-18.94%
2020-36.72%28.28%
2019-28.62%-230.88%
201821.87%-119.03%
2017-114.90%111.97%
2016-54.21%-68.97%
2015-174.69%158.45%

Transgene S.A. (TRGNF) Average ROE

How has TRGNF ROE performed in the past?

The current ROE of Transgene S.A. (TRGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-151.05%

5-year avg

-103.93%

10-year avg

-87.02%

Transgene S.A. (TRGNF) ROE vs. Peers

How is TRGNF’s ROE compared to its peers?

Transgene S.A.’s ROE is less than Hansa Biopharma AB (publ) (115.70%), greater than Silence Therapeutics plc (-85.88%), greater than Cellectis S.A. (-49.81%), greater than Immutep Limited (-38.87%), greater than Genfit S.A. (-63.70%), less than hVIVO plc (25.62%), greater than Santhera Pharmaceuticals Holding AG (-521.53%), greater than Mayne Pharma Group Limited (-22.99%), less than Probi AB (publ) (0.84%), less than Oryzon Genomics S.A. (-4.20%),

Build a custom stock screener for Transgene S.A. (TRGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Transgene S.A. (TRGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Transgene S.A.'s ROE?

How is the ROE calculated for Transgene S.A. (TRGNF)?

What is the highest ROE for Transgene S.A. (TRGNF)?

What is the 3-year average ROE for Transgene S.A. (TRGNF)?

What is the 5-year average ROE for Transgene S.A. (TRGNF)?

How does the current ROE for Transgene S.A. (TRGNF) compare to its historical average?